Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH agonist plus letrozole versus GnRH agonist alone for frozen embryo transfer in women with recurrent implantation failure
IRCT20181030041503N7Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of letrozole, triptorelin and estradiol in infertility and Recurrent Implantation Failure (RIF) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: chemical pregnancy rate, clinical pregnancy rate and 2 more. Started Oct 2023; status: completed.
02
Drugs
letrozoletriptorelinestradiol
03
Conditions
infertilityRecurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20181030041503N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181030041503N7.